Condition: Narcolepsy Type 1 · Sponsor: Takeda
Narcolepsy is a sleep disorder that disrupts a person's regular sleep-wake cycle. It causes extreme sleepiness during the day (called excessive daytime sleepiness \[EDS\]), where a person may fall asleep without warning. Narcolepsy Type 1 (NT1) is a form of the condition in which people also have sudden, unexpected muscle weakness while staying conscious (called cataplexy). The main aim of this study is to learn how safe TAK-360 is and how well adults with NT1 tolerate it. Adults who can participate in the study will have to stop taking their existing medicines for NT1 before study treatment starts. Participants may be randomly (by chance, like drawing names from a hat) assigned to get either TAK-360 or placebo during the treatment period. The placebo looks just like TAK-360 but does not have any medicine in it. After the treatment period, participants can be monitored for another 2 weeks. Participants can restart their usual NT1 treatment after study treatment ends. The participants will have to visit the clinic multiple times during this study.
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| Takeda Site 12 | Redwood City, California, United States | Not Yet Recruiting |
| Takeda Site 14 | Miami, Florida, United States | Recruiting |
| Takeda Site 13 | Cincinnati, Ohio, United States | Recruiting |
| Takeda Site 2 | Macquarie Park, New South Wales, Australia | Not Yet Recruiting |
| Takeda Site 4 | Beijing, Beijing Municipality, China | Recruiting |
| Takeda Site 3 | Guangzhou, Guangdong, China | Recruiting |
| Takeda Site 5 | Zhengzhou, Henan, China | Recruiting |
| Takeda Site 6 | Herault, Montpelier, France | Not Yet Recruiting |
| Takeda Site 7 | Paris, France | Not Yet Recruiting |
| Takeda Site 8 | Bologna, Emilia-Romagna, Italy | Not Yet Recruiting |
| Takeda Site 9 | Verona, Veneto, Italy | Not Yet Recruiting |
| Takeda Site 17 | Fukuoka, Fukuoka, Japan | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07633301